✦ LIBER ✦

PGI11 Economic Evaluation of the Use of Peg-Interferon Alfa 2A in the Treatment of Patients with Chronic Hepatitis C Public Mexican Perspective

✍ Scribed by D. Lechuga; M. Alva

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison between combination therapy w

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

PGI18 COST-EFFECTIVENESS ANALYSIS OF TRE

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PGI17 COST-EFFECTIVENESS ANALYSIS OF TRE

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Cost-effectiveness analysis of treatment

✍ Barros, Fabio MR; Cheinquer, Hugo; Tsuchiya, Carolina T; Santos, Eduardo AV 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 363 KB

PP-144 Influence of predictor variables

✍ N. Sargsyants 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Evaluation of the safety and efficacy of

✍ S. Zeuzem; S.V. Feinman; J. Rasenack; E.J. Heathcote; M.-Y. Lai; E. Gane; J. O'G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 166 KB